Anita Clayton has been a principal investigator in the clinical development of bremelanotide (PT-141) for female sexual dysfunction, leading multiple Phase 2 and Phase 3 trials that established the efficacy and safety profile supporting FDA approval
Store lyophilized MT-2 at -20C protected from light
Association between polymorphisms in glutathione peroxidase and selenoprotein P genes, glutathione peroxidase activity, HRT use and breast cancer risk
It may also be considered in supportive care conversations related to cataracts, glaucoma, aging, alcoholism, heart disease, liver disease, lung disease, Alzheimer's disease, Parkinson's disease, osteoarthritis, immune system concerns, and other chronic wellness concerns
Novo Nordisk's Wegovy had been the only FDA-approved GLP-1 pill available since December 2025
It will eventually improve adherence among patients who struggle with injection administration